Senior Medical Outcomes Liaison, Epilepsy and Rare Syndromes @ (October 2021 - January 2026)
RWE and Observational Research Lead @ (January 2020 - October 2021)
External Engagement, Scientific Communications and RWE Lead @ (January 2018 - January 2020)
Scientific Engagement and Publications Consultant, TMAC Advisors @ (January 2015 - January 2017)
Observational Research Lead, Theravance Biopharma @ (January 2013 - January 2015)
Neuroscience Medical Science Liaison, Alkermes @ (January 2011 - January 2013)
Group Editorial Director, Infectious Diseases @ (January 2006 - January 2009)
Medical Science and Publications Manager, Neuroscience @ (January 1999 - January 2006)
Epidemiologist, Division of STD, TB, and HIV Prevention @ (January 1996 - January 1999)
A. Manzo Education
Virginia Commonwealth University School of Medicine
Master of Public Health - MPH (Epidemiology)
Vanderbilt University
BA (English Literature)
Vanderbilt Michael B. Keegan Traveling Fellows
A. Manzo Skills
Medical Writing
Neuroscience
Life Sciences
Social Media
Project Management
Sales
Key Opinion Leaders
Publication Planning
Leadership
Medical Education
Clinical Research
Clinical Development
Neurology
Medical Affairs
Healthcare
Pharmaceutical Industry
A. Manzo Summary
A. Manzo, based in San Francisco, CA, US, is currently a Director, Scientific Publications at Xenon Pharmaceuticals Inc.. A. Manzo brings experience from previous roles at UCB, Corcept Therapeutics, Osmotica Pharmaceutical Corp. and The Medical Affairs Company (TMAC). A. Manzo holds a Master of Public Health - MPH in Epidemiology @ Virginia Commonwealth University School of Medicine. With a robust skill set that includes Medical Writing, Neuroscience, Life Sciences, Social Media, Project Management and more. A. Manzo has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different A. Manzo?
Find contact details for 700 million professionals.